Growth and Laboratory Maintenance of Staphylococcus aureus

Dominique M. Missiakas1, Olaf Schneewind1

1 Department of Microbiology, University of Chicago, Chicago, Illinois
Publication Name:  Current Protocols in Microbiology
Unit Number:  Unit 9C.1
DOI:  10.1002/9780471729259.mc09c01s28
Online Posting Date:  February, 2013
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Staphylococcus aureus is a facultative anaerobic Gram‐positive coccus and a member of the normal skin flora as well as the nasal passages of humans. S. aureus is also the etiological agent of suppurative abscesses, as first described by Sir Alexander Ogston in 1880. Ever since, studies on S. aureus have focused on the complex battery of virulence factors and regulators that allow for its swift transition between commensalism and pathogenic states and escape from host immune defenses. The success of this pathogen is further evidenced by its ability to acquire antibiotic resistance traits through mechanisms that often remain poorly understood. Curr. Protoc. Microbiol. 28:9C.1.1‐9C.1.9. © 2013 by John Wiley & Sons, Inc.

Keywords: Staphylococcus aureus; Gram positive; coccus; MRSA

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Strategic Planning
  • Basic Protocol 1: Growth of S. aureus from a Frozen Stock
  • Basic Protocol 2: Growth of S. aureus in Liquid Medium
  • Basic Protocol 3: Preparation of S. aureus Frozen Stocks
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Growth of S. aureus from a Frozen Stock

  Materials
  • S. aureus frozen stock (see protocol 3)
  • TSA plates with antibiotics, if necessary (see Table 9.1.1)
  • Protective laboratory coat, eye goggles and disposable latex gloves
  • Disposable sterile loop
  • 37°C incubator
    Table 9.0.1   MaterialsAntibiotic Usage for S. aureus

    Antibiotic a Range of final concentration (µg/ml) b Stock (mg/ml) c
    Chloramphenicol 10‐20 20
    Tetracycline 5‐10 10
    Spectinomycin 10‐20 20
    Erythromycin 5‐50 50
    Kanamycin 20‐25 25

     aList of the most commonly used antibiotics.
     bThe specific concentration of antibiotic may vary depending on the strain (owing to intrinsic resistance) and increases with the copy number of the cognate resistance marker (chromosome: single copy; plasmid: multiple copies).
     cAll antibiotics are acquired as powder products; they are weighed, dissolved, filtered, and stored. Antibiotics stocks may be stored frozen at −20°C for several months or kept at 4°C for several weeks. Stocks should not be re‐frozen and should be kept on ice when not stored at 4°C. Chloramphenicol and erythromycin are dissolved in 100% ethanol. Tetracycline is dissolved in 70% ethanol and should be kept in the dark because it is light‐sensitive. Spectinomycin and kanamycin are both dissolved in water. Methods to prepare and store antibiotic solutions can be found in manuals for molecular genetics and molecular biology work (Miller, ; Sambrook and Russell, ).

Basic Protocol 2: Growth of S. aureus in Liquid Medium

  Materials
  • Sterile medium (e.g., TSB, see recipe)
  • Antibiotics, if necessary (see Table 9.1.1)
  • S. aureus colonies freshly grown on TSA (see protocol 1)
  • Sterile glass tubes (e.g., 18‐mm) or flasks (e.g., 125‐ml)
  • Disposable sterile loop
  • 37°C incubator with a shaker at 200 rpm or a roller drum (tube only)

Basic Protocol 3: Preparation of S. aureus Frozen Stocks

  Materials
  • S. aureus freshly grown on TSA (see protocol 1)
  • S. aureus freshly grown in TSB
  • 50% and 10% glycerol, sterile
  • 1× or 2× cryopreservation solution (see recipe)
  • Sterile pipets
  • 2‐ml sterile cryogenic vials
  • Sterile loop
  • −80°C freezer
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Arbeit, R.D., Maki, D., Tally, F.P., Campanaro, E., and Eisenstein, B.I. 2004. The safety and efficacy of daptomycin for the treatment of complicated skin and skin‐structure infections. Clin. Infect. Dis. 38:1673‐1681.
   Baba, T., Bae, T., Schneewind, O., Takeuchi, F., and Hiramatsu, K. 2007. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes. J. Bacteriol. 190:300‐310.
   Bae, T. and Schneewind, O. 2005. Allelic replacement in Staphylococcus aureus with inducible counter‐selection. Plasmid 55:58‐63.
   Bae, T., Banger, A.K., Wallace, A., Glass, E.M., Aslund, F., Schneewind, O., and Missiakas, D.M. 2004. Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc. Natl. Acad. Sci. U.S.A. 101:12312‐12317.
   Bernheimer, A.W., Avigad, L.S., and Grushoff, P. 1968. Lytic effects of staphylococcal alpha‐toxin and delta‐hemolysin. J. Bacteriol. 96:487‐491.
   Brumfitt, W. and Hamilton‐Miller, J. 1989. Methicillin‐resistant Staphylococcus aureus. N. Engl. J. Med. 320:1188‐1199.
   Chang, S., Sievert, D.M., Hageman, J.C., Boulton, M.L., Tenover, F.C., Downes, F.P., Shah, S., Rudrik, J.T., Pupp, G.R., Brown, W.J., Cardo, D., and Fridkin, S.K. 2003. Infection with vancomycin‐resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342‐1347.
   Cheng, A.G., Kim, H.K., Burts, M.L., Krausz, T., Schneewind, O., and Missiakas, D.M. 2009. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 23:3393‐3404.
   Cheng, A.G., DeDent, A.C., Schneewind, O., and Missiakas, D. 2011. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol. 19:225‐232.
   de Jonge, B.L.M., Chang, Y.S., Gage, D., and Tomasz, A. 1992. Peptidoglycan composition in heterogeneous Tn551 mutants of a methicillin‐resistant Staphylococcus aureus strain. J. Biol. Chem. 267:11255‐11259.
   Diep, B.A., Gill, S.R., Chang, R.F., Phan, T.H., Chen, J.H., Davidson, M.G., Lin, F., Lin, J., Carleton, H.A., Mongodin, E.F., Sensabaugh, G.F., and Perdreau‐Remington, F. 2006. Complete genome sequence of USA300, an epidemic clone of community‐acquired meticillin‐resistant Staphylococcus aureus. Lancet 367:731‐739.
   Dinges, M.M., Orwin, P.M., and Schlievert, P.M. 2000. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 13:16‐34.
   Duthie, E.S. 1954. Evidence for two forms of staphylococcal coagulase. J. Gen. Microbiol. 10:427‐436.
   Edwards, A.M. 2012. Phenotype‐switching is a natural consequence of Staphylococcus aureus replication. J. Bacteriol. 194:5404‐5412.
   Enright, M.C., Day, N.P.J., Davies, C.E., Peacock, S.J., and Spratt, B.G. 2000. Multilocus sequence typing for characterization of methicillin‐resistant and methicillin‐susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008‐1015.
   Forsgren, A. and Sjöquist, J. 1966. Protein A from S. aureus. I. Pseudo‐immune reaction with human gamma‐globulin. J. Immunol. 97:822‐827.
   Giesbrecht, P., Kersten, T., Maidhof, H., and Wecke, J. 1998. Staphylococcal cell wall: Morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62:1371‐1414.
   Gillaspy, A.F., Hickmon, S.G., Skinner, R.A., Thomas, J.R., Nelson, C.L., and Smeltzer, M.S. 1995. Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect. Immun. 63:3373‐3380.
   Gorwitz, R.J., Kruszon‐Moran, D., McAllister, S.K., McQuillan, G., McDougal, L.K., Fosheim, G.E., Jensen, B.J., Killgore, G., Tenover, F.C., and Kuehnert, M.J. 2008. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001‐2004. J. Infect. Dis. 197:1226‐1234.
   Götz, F., Bannerman, T., and Schleifer, K.‐H. 2006. The genera Staphylococcus and Macrococcus. In The Prokaryotes (M. Dworkin, S. Falkow, E. Rosenberg, K.‐H. Schleifer, and E. Stackebrandt, eds.) pp. 5‐75. Springer, New York.
   Gründling, A. and Schneewind, O. 2007. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 104:8478‐8483.
   Harris, S.R., Feil, E.J., Holden, M.T., Quail, M.A., Nickerson, E.K., Chantratita, N., Gardete, S., Tavares, A., Day, N., Lindsay, J.A., Edgeworth, J.D., de Lencastre, H., Parkhill, J., Peacock, S.J., and Bentley, S.D. 2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327:469‐474.
   Herold, B.C., Immergluck, L.C., Maranan, M.C., Lauderdale, D.S., Gaskin, R.E., Boyle‐Vavra, S., Leitch, C.D., and Daum, R.S. 1998. Community‐acquired methicillin‐resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593‐598.
   Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T., and Tenover, F.C. 1997. Methicillin‐resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135‐136.
   Iordanescu, S. and Surdeanu, M. 1976. Two restriction and modification systems in Staphylococcus aureus NCTC8325. J. Gen. Microbiol. 96:277‐281.
   Kennedy, A.D., Otto, M., Braughton, K.R., Whitney, A.R., Chen, L., Mathema, B., Mediavilla, J.R., Byrne, K.A., Parkins, L.D., Tenover, F.C., Kreiswirth, B.N., Musser, J.M., and DeLeo, F.R. 2008. Epidemic community‐associated methicillin‐resistant Staphylococcus aureus: Recent clonal expansion and diversification. Proc. Natl. Acad. Sci. U.S.A. 105:1327‐1332.
   Kreiswirth, B.N., Lofdahl, S., Betley, M.J., O'Reilly, M., Schlievert, P.M., Bergdoll, M.S., and Novick, R.P. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709‐712.
   Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, L., Cui, L., Oguchi, A., Aoki, K., Nagai, Y., Lian, J., Ito, T., Kanamori, M., Matsumaru, H., Maruyama, A., Murakami, H., Hosoyama, A., Mizutani‐Ui, Y., Takahashi, N.K., Sawano, T., Inoue, R., Kaito, C., Sekimizu, K., Hirakawa, H., Kuhara, S., Goto, S., Yabuzaki, J., Kanehisa, M., Yamashita, A., Oshima, K., Furuya, K., Yoshino, C., Shiba, T., Hattori, M., Ogasawara, N., Hayashi, H., and Hiramatsu, K. 2001. Whole genome sequencing of methicillin‐resistant Staphylococcus aureus. Lancet 357:1225‐1240.
   Lee, C.Y. and Iandolo, J.J. 1986. Integration of staphylococcal phage L54a occurs by site‐specific recombination: Structural analysis of the attachment sites. Proc. Natl. Acad. Sci. U.S.A. 83:5474‐5478.
   Lee, C.Y., Buranen, S.L., and Ye, Z.‐H. 1991. Construction of single‐copy integration vectors for Staphylococcus aureus. Gene 103:101‐105.
   Loeb, L. 1903. The Influence of certain bacteria on the coagulation of the blood. J. Med. Res. 10:407‐419.
   Lowy, F.D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520‐532.
   Ma, X.X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle‐Vavra, S., Daum, R.S., and Hiramatsu, K. 2002. Novel type of staphylococcal cassette chromosome mec identified in community‐acquired methicillin resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 46:1147‐1152.
   McAdam, P.R., Templeton, K.E., Edwards, G.F., Holden, M.T., Feil, E.J., Aanensen, D.M., Bargawi, H.J., Spratt, B.G., Bentley, S.D., Parkhill, J., Enright, M.C., Holmes, A., Girvan, E.K., Godfrey, P.A., Feldgarden, M., Kearns, A.M., Rambaut, A., Robinson, D.A., and Fitzgerald, J.R. 2012. Molecular tracing of the emergence, adaptation, and transmission of hospital‐associated methicillin‐resistant Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 109:9107‐9112.
   McCarthy, A.J., Lindsay, J.A., and Loeffler, A. 2012. Are all meticillin‐resistant Staphylococcus aureus (MRSA) equal in all hosts? Epidemiological and genetic comparison between animal and human MRSA. Vet. Dermatol. 23:267‐275.
   Miller, J.H. 1992. A Short Course in Bacterial Genetics. Cold Spring Harbor Laboratory Press, New York.
   Much, H. 1908. Über eine vorstufe des fibrinfermentes in kulturen von Staphylokokkus aureus. Biochem. Z. 14:143‐155.
   Neu, H.C. 1992. The crisis in antibiotic resistance. Science 257:1064‐1073.
   Novick, R. 1967. Properties of a cryptic high‐frequency transducing phage in Staphylococcus aureus. Virology 33:155‐166.
   Novick, R.P. 1990. The Staphylococcus as a molecular genetic system. In Molecular Biology of the Staphylococci (R.P. Novick, ed.) pp. 1‐40. VCH Publishers, New York.
   Novick, R.P. and Subedi, A. 2007. The SaPIs: Mobile pathogenicity islands of Staphylococcus. Chem. Immunol. Allergy 93:42‐57.
   Novick, R.P. and Geisinger, E. 2008. Quorum sensing in staphylococci. Annu. Rev. Genet. 42:541‐564.
   O'Riordan, K. and Lee, J.C. 2004. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17:218‐234.
   Ogston, A. 1883. Micrococcus poisoning. J. Anat. Physiol. 17:24‐58.
   Proctor, R.A., Kahl, B., von Eiff, C., Vaudaux, P.E., Lew, D.P., and Peters, G. 1998. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin. Infect. Dis. 27:S68‐S74.
   Reizer, J., Hoischen, C., Titgemeyer, F., Rivolta, C., Rabus, R., Stulke, J., Karamata, D., Saier, M.H. Jr., and Hillen, W. 1998. A novel protein kinase that controls carbon catabolite repression in bacteria. Mol. Microbiol. 27:1157‐1169.
   Rosenbach, F.J. 1884. Mikroorganismen bei den Wundinfections‐Krankheiten des Menschen. Wiesbaden, Germany.
   Rosenstein, R. and Gotz, F. 2000. Staphylococcal lipases: Biochemical and molecular characterization. Biochimie 82:1005‐1014.
   Rudin, L., Sjostrom, J.E., Lindberg, M., and Philipson, L. 1974. Factors affecting competence for transformation in Staphylococcus aureus. J. Bacteriol. 118:155‐164.
   Sambrook, J. and Russell, D.W. 2006. The Condensed Protocols from Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Schlag, S., Nerz, C., Birkenstock, T.A., Altenberend, F., and Götz, F. 2007. Inhibition of staphylococcal biofilm formation by nitrite. J. Bacteriol. 189:7911‐7919.
   Somerville, G.A., Beres, S.B., Fitzgerald, J.R., DeLeo, F.R., Cole, R.L., Hoff, J.S., and Musser, J.M. 2002. In vitro serial passage of Staphylococcus aureus: Changes in physiology, virulence factor production, and agr nucleotide sequence. J. Bacteriol. 184:1430‐1437.
   Stevens, D.H., Herr, D., Campiris, H., Hunt, J.L., Batts, D.H., and Hafkin, B. 2002. Linezolid versus vancomycin for the treatment of methicillin‐resistant Staphylococcus aureus infections. Clin. Infect. Dis. 34:1481‐1490.
   Sun, F., Cho, H., Jeong, D.W., Li, C., He, C., and Bae, T. 2010. Aureusimines in Staphylococcus aureus are not involved in virulence. PLoS One 5:e15703.
   Tzagoloff, H. and Novick, R. 1977. Geometry of cell division in Staphylococcus aureus. J. Bacteriol. 129:343‐350.
   van Hal, S.J. and Paterson, D.L. 2011. New Gram‐positive antibiotics: Better than vancomycin? Curr. Opin. Infect. Dis. 24:515‐520.
   Vandenesch, F., Kornblum, J., and Novick, R.P. 1991. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J. Bacteriol. 173:6313‐6320.
   von Eiff, C., Heilmann, C., Proctor, R.A., Woltz, C., Peters, G., and Gotz, F. 1997. A site‐directed Staphylococcus aureus hemB mutant is a small‐colony variant which persists intracellularly. J. Bacteriol. 179:4706‐4712.
   Waldron, D.E. and Lindsay, J.A. 2006. Sau1: A novel lineage‐specific type I restriction‐modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J. Bacteriol. 188:5578‐5585.
   Walsh, C.T. 1993. Vancomycin resistance: Decoding the molecular logic. Science 261:308‐309.
   Wang, R., Braughton, K.R., Kretschmer, D., Bach, T.H., Queck, S.Y., Li, M., Kennedy, A.D., Dorward, D.W., Klebanoff, S.J., Peschel, A., DeLeo, F.R., and Otto, M. 2007. Identification of novel cytolytic peptides as key virulence determinants for community‐associated MRSA. Nat. Med. 13:1510‐1514.
   Weigel, L.M., Clewell, D.B., Gill, S.R., Clark, N.C., McDougal, L.K., Flannagan, S.E., Kolonay, J.F., Shetty, J., Killgore, G.E., and Tenover, F.C. 2003. Genetic analysis of a high‐level vancomycin‐resistant isolate of Staphylococcus aureus. Science 302:1569‐1571.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library